Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review

Background: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We rep...

Full description

Bibliographic Details
Main Authors: Ronie Romelean Jayapalan, Kein Seong Mun, Kum Thong Wong, Sheau Fung Sia
Format: Article
Language:English
Published: Elsevier 2019-04-01
Series:World Neurosurgery: X
Online Access:http://www.sciencedirect.com/science/article/pii/S2590139718300061
id doaj-39cd3f59f57a4e28bbb8ef0488e9277d
record_format Article
spelling doaj-39cd3f59f57a4e28bbb8ef0488e9277d2020-11-25T02:13:00ZengElsevierWorld Neurosurgery: X2590-13972019-04-012Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature ReviewRonie Romelean Jayapalan0Kein Seong Mun1Kum Thong Wong2Sheau Fung Sia3Division of Neurosurgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; To whom correspondence should be addressed: Ronie Romelean Jayapalan, M.B.B.S., M.R.C.S.Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaDepartment of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaDivision of Neurosurgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaBackground: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We report a 42-year-old man, diagnosed with rosette-forming glioneuronal tumor of the fourth ventricle with a positive isocitrate dehydrogenase 1 mutation, progressed to glioblastoma after 6 years from diagnosis. We discuss the clinical history, radiological findings, and histopathological characteristic with immunohistochemistry findings observed in this unique case. Conclusions: Despite being acceptable as benign, based on our observations in this case, there is a potential for malignant transformation of rosette-forming glioneuronal tumor. The role of isocitrate dehydrogenase 1 mutation leading to malignant transformation could not be established as our finding is novel and further prospective studies are required to prove this association. Key words: Glioblastoma IDH mutant, IDH 1 mutation, Malignant transformation, RGNThttp://www.sciencedirect.com/science/article/pii/S2590139718300061
collection DOAJ
language English
format Article
sources DOAJ
author Ronie Romelean Jayapalan
Kein Seong Mun
Kum Thong Wong
Sheau Fung Sia
spellingShingle Ronie Romelean Jayapalan
Kein Seong Mun
Kum Thong Wong
Sheau Fung Sia
Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
World Neurosurgery: X
author_facet Ronie Romelean Jayapalan
Kein Seong Mun
Kum Thong Wong
Sheau Fung Sia
author_sort Ronie Romelean Jayapalan
title Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
title_short Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
title_full Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
title_fullStr Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
title_full_unstemmed Malignant Transformation of a Rosette-Forming Glioneuronal Tumor with IDH1 Mutation: A Case Report and Literature Review
title_sort malignant transformation of a rosette-forming glioneuronal tumor with idh1 mutation: a case report and literature review
publisher Elsevier
series World Neurosurgery: X
issn 2590-1397
publishDate 2019-04-01
description Background: Rosette-forming glioneuronal tumor (World Health Organization grade I) is considered as a benign tumor with very low potential for progression. The potential for malignant transformation of this tumor is not known and has never been reported before in literature. Case Description: We report a 42-year-old man, diagnosed with rosette-forming glioneuronal tumor of the fourth ventricle with a positive isocitrate dehydrogenase 1 mutation, progressed to glioblastoma after 6 years from diagnosis. We discuss the clinical history, radiological findings, and histopathological characteristic with immunohistochemistry findings observed in this unique case. Conclusions: Despite being acceptable as benign, based on our observations in this case, there is a potential for malignant transformation of rosette-forming glioneuronal tumor. The role of isocitrate dehydrogenase 1 mutation leading to malignant transformation could not be established as our finding is novel and further prospective studies are required to prove this association. Key words: Glioblastoma IDH mutant, IDH 1 mutation, Malignant transformation, RGNT
url http://www.sciencedirect.com/science/article/pii/S2590139718300061
work_keys_str_mv AT ronieromeleanjayapalan malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview
AT keinseongmun malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview
AT kumthongwong malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview
AT sheaufungsia malignanttransformationofarosetteformingglioneuronaltumorwithidh1mutationacasereportandliteraturereview
_version_ 1724906859342594048